Cargando…
IgG1-b12–HIV-gp120 Interface in Solution: A Computational Study
[Image: see text] The use of broadly neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) has been shown to be a promising therapeutic modality in the prevention of HIV infection. Understanding the b12–gp120 binding mechanism under physiological conditions may assist the devel...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2021
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790758/ https://www.ncbi.nlm.nih.gov/pubmed/34971312 http://dx.doi.org/10.1021/acs.jcim.1c01143 |